Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects With Hypertension, in the Absence of Antihypertensive Medications

NCT03503773 is registered in ClinicalTrials.gov with Ablative Solutions, Inc. as lead sponsor.

NCT NCT03503773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03503773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects With Hypertension, in the Absence of Antihypertensive Medications
Lead sponsor
Ablative Solutions, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 24, 2018
Completion date
January 10, 2024
Enrollment
350 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, hypertension,essential